Fiber medicine

Hollow Fiber Filtration Market Size Will Reach USD 881.53 Million in 2028 | Reports and data

Rising inclination towards continuous manufacturing, rapid growth in the biologics market, and increasing growth opportunities in the biopharmaceutical sector are key factors driving the growth of the market

New York, January 13, 2021 – The Global hollow fiber filtration market the size is expected to reach USD 881.53 million in 2028 at a CAGR of 13.8%, according to the latest Reports and Data report. The increasing preference for continuous manufacturing in the biopharmaceutical industry, the growing demand for biologics due to the increasing prevalence of chronic diseases, and the growing demand for water and wastewater treatment are key factors that are expected to drive the market revenue growth over the forecast period. Rapid developments in the pharmaceutical and biotechnology sectors and growing awareness about the benefits of biopharmaceuticals are also expected to support the market growth over the forecast period.

Request a free sample of this research report at:

Hollow fiber filtration utilizes a small tube diameter which allows for flexibility and increases its application in reverse osmosis pretreatment, industrial wastewater treatment, and downstream biotechnology and pharmaceutical processes. Hollow fiber filtration uses a large number of long and porous filaments, which are 1-3.5mm wide and packed in a PVC shell. Hollow fiber membranes have a very high packing density, which increases the flexibility of the strands that allow certain filter configurations. Single-use hollow fiber filters are covered with housings designed to withstand high process pressures; from process development to manufacturing, and are ideally suited for ultrafiltration, diafiltration and microfiltration. This is expected to further drive the market revenue growth over the forecast period. Hollow fiber filter technology was developed for dialysis filtration but currently has a wide range of applications including compressed air sterilization. This is expected to further fuel the market revenue growth over the forecast period.

Increasing automation of manufacturing processes through continuous manufacturing to improve the scalability of production of therapeutic proteins, vaccines, and other biologics is also expected to drive the market growth during the forecast period. Hollow fiber filters are used to transport drugs owing to their high surface area to volume ratio and their high efficiency is expected to drive the adoption of hollow fiber filters in the pharmaceutical sector, which is further expected to drive the market revenue growth . However, stringent regulations regarding drug safety and lack of awareness about the benefits of hollow fiber filters are expected to limit the market growth to some extent over the forecast period.

To identify key industry trends, click the link below:

Some key highlights of the report:

  • The microfiltration segment is expected to account for a major revenue share in the global market over the forecast period owing to the increasing adoption of microfiltration with hollow fiber filters in various biopharmaceutical processes such as cell harvesting, clarification, purification of cell broths and recovery processes in the production of antibiotics.
  • The polymer segment is expected to register significant revenue growth over the forecast period owing to the increasing application of polymer hollow fiber filters in ultrafiltration, microfiltration and other biochemical processes. Additionally, easy manufacturing, high filtration capacity and increased energy efficiency are also expected to contribute to the revenue growth of the segment over the forecast period.
  • The infusion segment is expected to register a rapid revenue CAGR during the forecast period owing to the growing need to reduce the time and cost of manufacturing processes and increasing applications in the biopharmaceutical sector to obtain production uninterrupted supply of vaccines and other biological products.
  • Pharmaceutical manufacturers segment is expected to account for considerable revenue share in the global market over the forecast period due to growing demand for bioprocessing products, increase in biologics research, advancements technologies in the pharmaceutical sector and the increasing adoption of continuous manufacturing techniques.
  • Asia-Pacific is expected to register a CAGR of 11.9% during the forecast period owing to growing CRO penetration, increasing outsourcing activities in the region, rapid development of healthcare infrastructure and the growth of the pharmaceutical sector.
  • In December 2020, Sartorius, which is a global leader in life sciences, announced the acquisition of WaterSep BioSeparations LLC, which is a leading developer, manufacturer and distributor of hollow fiber membrane devices and presterilized assemblies. for upstream and downstream biopharmaceutical applications.

Major companies operating in the market include:

  • Asahi Kasei Society
  • Repligen Corporation
  • GE Healthcare
  • Danaher Company
  • Parker-Hannifin Corporation
  • Koch Membrane Systems, Inc.
  • Watersep bioseparation company
  • Toyobo Co., Ltd.
  • Microdyn-Nadir GmbH
  • Cantel Medical Corporation
  • Coorstek, Inc.

Order now:

For the purposes of this report, Reports and Data has segmented the global hollow fiber filtration market on the basis of technique, material, application, end-use industry and region:

Technical Outlook (Revenue, USD Million; 2018-2028)

  • Microfiltration
  • Ultrafiltration
  • Reverse osmosis

Material Outlook (Revenue, USD Million; 2018-2028)

Application Outlook (Revenue, USD Million; 2018-2028)

  • Harvest & Clarification
  • Concentration
  • infusion

End-Use Industry Outlook (Revenue, USD Million; 2018-2028)

  • Pharmaceutical manufacturers
  • CRO
  • CMO

Regional Outlook (Revenue, USD Million; 2018-2028)

  • North America
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • The rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of APAC
  • Latin America
  • Middle East and Africa
    • Saudi Arabia
    • United Arab Emirates
    • South Africa
    • Rest of MEA

Browse similar research reports:

Mouse Models Market Sizing, sharing, and analysis, by type of mouse (inbred, outbred, knockout, hybrid, other), technology (CRISPR, microinjection, embryonic stem cell injection, nuclear transfer, other), by use (human and veterinary) , by application (academic, infectious disease research and development, other), by end use (academic and research institute, pharmaceutical, biotech, cosmetic, other) and by region, forecast to 2028

Physical Vapor Deposition (PVD) Medical Devices Market Size, Sharing, and Analysis, by Type (General Surgery Equipment, Medical Testing Devices, Laparoscopic Instruments, Heart Stents, Dental Implants, Ventilator Parts, Needles, Pacemakers, Others), by Application (Hospitals and Clinics, Surgical Centers , others), and Forecast by region until 2028

Slide Dyes Market Size, sharing and analysis, by product type (reagents, consumables and accessories, equipment), by technology (immunohistochemistry, hematoxylin and eosin, in situ hybridization, cytology, hematology, microbiology, specialty stains), by end use (hospitals and clinics , diagnostic centers, pharmaceutical and biotechnology companies, academic and research institutes, others), and forecasts by region until 2028

Compound Management Market Size, Share & Analyze, By Type (Automated Compound/Sample Storage Systems, Automated Liquid Handling Systems, Outsourcing Services, Others), By Sample Type (Chemical Compounds, Biological Samples, Others), By Application (drug discovery, biobanks, gene synthesis, others), by end use (pharmaceutical companies, biopharmaceutical companies, research institutes and academics, contract research organizations (CROs), others) and by region Forecast to 2028

Vascular Graft Market Size, Sharing, and Analysis, by Type (Hemodialysis Grafts, Coronary Bypass Grafts, Peripheral Vascular Grafts, Coronary Stents, Others), by Raw Material (Polyester Grafts, ePTFE, Polyurethane Grafts, Biosynthetic Grafts), by Application ( coronary bypass, aneurysms, renal bypass, chronic total occlusion), and by end use (hospitals, ambulatory surgery centers, specialty clinics, other), and by region, forecast to 2028

About reports and data

Reports and Data is a market research and consulting firm that provides syndicated research reports, custom research reports and consulting services. Our solutions are uniquely focused on your goal to locate, target and analyze changes in consumer behavior across demographics, across industries and help customers make a smarter business decision. We offer market intelligence research ensuring relevant, fact-based research across multiple sectors including healthcare, technology, chemicals, power and energy. We are constantly updating our search offerings to ensure that our clients are aware of the latest trends existing in the market. Reports and Data has a strong base of experienced analysts from a variety of areas of expertise.

Contact us:

Jean W

Head of Business Development

Reports and data | The Web:

Direct line: +1-212-710-1370

E-mail: [email protected]

Read the full press release: